As already highlighted, GmCSF and b7.1 are key molecules in inducing robust immune responses, which may facilitate subsequent antitumour immunity.27, 28 Indeed, only those mice treated with pEEVGmCSF-b7.1 were observed to have reduced or absent primary tumour growth, which paralleled to significantly improved survival rates. The gene discussed is CSF2; the disease is neoplasm.